Nicolas Leupin
Chief Tech/Sci/R&D Officer at NOVOCURE LIMITED
Net worth: 918 078 $ as of 31/03/2024
Profile
Nicolas Leupin is currently the Chief Medical Officer at NovoCure Ltd.
He previously held the same position at Molecular Partners AG from 2019 to 2023 and at argenx SE from 2016 to 2019.
He was also a member of the Swiss Group for Clinical Research.
Leupin holds an MBA from Jones International University and a doctorate from the University of Bern.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD.
0.05% | 27/02/2024 | 51,124 ( 0.05% ) | 799 068 $ | 31/03/2024 |
MOLECULAR PARTNERS AG
0.08% | 31/12/2023 | 29,168 ( 0.08% ) | 119 010 $ | 31/03/2024 |
Nicolas Leupin active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 04/01/2024 |
Former positions of Nicolas Leupin
| Companies | Position | End |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 24/08/2023 |
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Training of Nicolas Leupin
| Jones International University | Masters Business Admin |
| University of Bern | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| ARGENX SE | Health Technology |
| Private companies | 1 |
|---|---|
| Swiss Group for Clinical Research |
- Stock Market
- Insiders
- Nicolas Leupin
